Akebia Therapeutics Inc (STU:AX9) Stock News, Headlines & Updates
Akebia Therapeutics Inc Stock News from GuruFocus
- 1
Jul 08, 2025
Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference
Marketwired • 7:00am
Jul 01, 2025
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | AKBA Stock News
GuruFocus News • 3:18pm
Jun 04, 2025
Akebia (AKBA) Publishes Phase 3 Clinical Trial Analysis | AKBA Stock News
GuruFocus News • 7:20am
Akebia Therapeutics (AKBA) Receives 'Buy' Rating from HC Wainwright & Co. | AKBA Stock News
GuruFocus News • 7:00am
Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology
Marketwired • 7:00am
Akebia (AKBA) Receives Buy Rating with Promising Outlook for Vafseo | AKBA Stock News
GuruFocus News • 5:30am
Jun 02, 2025
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | AKBA Stock News
GuruFocus News • 3:17pm
May 28, 2025
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
Marketwired • 7:00am
May 27, 2025
Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025
Marketwired • 7:00am
May 13, 2025
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
Marketwired • 7:00am
May 09, 2025
Akebia Therapeutics Inc (AKBA) Q1 2025 Earnings Call Highlights: Strong Revenue Performance and Strategic Market Penetration
GuruFocus News • 1:11am
Q1 2025 Akebia Therapeutics Inc Earnings Call Transcript
GuruFocus News • 11:15pm
May 08, 2025
Akebia Therapeutics (AKBA) Sees Strong Q1 Revenue Growth Fueled by Vafseo
GuruFocus News • 12:01pm
Akebia (AKBA) Surpasses Revenue Expectations with Strong Vafseo Debut | AKBA Stock News
GuruFocus News • 6:47am
Akebia Therapeutics Inc Q1 2025 Earnings: EPS of $0.04, Revenue Surges to $57.3 Million, Beating Estimates
GuruFocus News • 6:38am
Akebia Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
Marketwired • 6:00am
May 07, 2025
Earnings To Watch: Akebia Therapeutics Inc (AKBA) Reports Q1 2025 Result
GuruFocus News • 8:44am
May 01, 2025
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Akebia Therapeutics to Report First Quarter 2025Â Financial Results and Discuss Recent Business Highlights
Marketwired • 7:00am
Apr 28, 2025
Akebia (AKBA) Secures Strong Position with Vafseo Launch for Anemia Treatment | AKBA Stock News
GuruFocus News • 6:19am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news